BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+9.3%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.38T
AUM Growth
+$191B
(+6%)
Cap. Flow
-$3.43B
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
19.49%
Holding
5,762
New
69
Increased
2,342
Reduced
2,465
Closed
253
Top Buys
| 1 |
GE HealthCare
GEHC
|
+$2.19B |
| 2 |
Microsoft
MSFT
|
+$1.59B |
| 3 |
Amazon
AMZN
|
+$1.33B |
| 4 |
NVIDIA
NVDA
|
+$1.07B |
| 5 |
Linde
LIN
|
+$984M |
Top Sells
| 1 |
GE Aerospace
GE
|
+$1.86B |
| 2 |
Exxon Mobil
XOM
|
+$1.45B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.1B |
| 4 |
SIVB
SVB Financial Group
SIVB
|
+$1.1B |
| 5 |
STOR
STORE Capital Corporation
STOR
|
+$936M |
Sector Composition
| 1 | Technology | 24.43% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.81% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Crawford & Co Class A
CRD.A
$540M
| $12.2M | ﹤0.01% |
1,453,705
-175,247
| -11% | -$1.47M |
|
3102
BlackRock ETF Trust II iShares AAA CLO Active ETF
CLOA
$1.18B
| $12.1M | ﹤0.01% |
+240,000
| New | +$12.1M |
|
3103
Village Super Market
VLGEA
$573M
| $12.1M | ﹤0.01% |
529,728
-11,505
| -2% | -$263K |
|
3104
HighPeak Energy
HPK
$904M
| $12.1M | ﹤0.01% |
526,886
+27,212
| +5% | +$626K |
|
|
JBIO
3105
Jade Biosciences, Inc. Common Stock
JBIO
$227M
| $12.1M | ﹤0.01% |
17,143
-228
| -1% | -$161K |
|
3106
Third Coast Bancshares
TCBX
$555M
| $12.1M | ﹤0.01% |
769,816
+630
| +0.1% | +$9.9K |
|
|
HLTH
3107
DELISTED
Cue Health Inc. Common Stock
HLTH
| $12.1M | ﹤0.01% |
6,635,942
-181,529
| -3% | -$330K |
|
3108
PepGen
PEPG
$61.3M
| $12.1M | ﹤0.01% |
987,150
+11,478
| +1% | +$140K |
|
|
NUTX
3109
Nutex Health
NUTX
$501M
| $12M | ﹤0.01% |
79,439
+2,702
| +4% | +$409K |
|
3110
iShares Core Conservative Allocation ETF
AOK
$641M
| $12M | ﹤0.01% |
344,222
-8,762
| -2% | -$306K |
|
|
BCOV
3111
DELISTED
Brightcove, Inc.
BCOV
| $12M | ﹤0.01% |
2,702,268
+95,581
| +4% | +$425K |
|
|
ALPN
3112
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $12M | ﹤0.01% |
1,552,920
+116,060
| +8% | +$896K |
|
3113
Prospect Capital
PSEC
$1.28B
| $12M | ﹤0.01% |
1,719,093
-428,813
| -20% | -$2.98M |
|
|
FINV
3114
FinVolution Group
FINV
$2.02B
| $12M | ﹤0.01% |
2,868,772
+14,206
| +0.5% | +$59.2K |
|
3115
Noodles & Co
NDLS
$30.7M
| $12M | ﹤0.01% |
2,465,287
-71,198
| -3% | -$345K |
|
3116
Fulcrum Therapeutics
FULC
$396M
| $11.9M | ﹤0.01% |
4,183,738
+914,747
| +28% | +$2.61M |
|
3117
Korea Electric Power
KEP
$17.3B
| $11.9M | ﹤0.01% |
1,715,054
-442,904
| -21% | -$3.07M |
|
3118
Blend Labs
BLND
$1.1B
| $11.8M | ﹤0.01% |
11,891,034
-183,780
| -2% | -$183K |
|
3119
Y-mAbs Therapeutics
YMAB
| $11.8M | ﹤0.01% |
2,361,093
-217,683
| -8% | -$1.09M |
|
3120
5E Advanced Materials
FEAM
$89.8M
| $11.8M | ﹤0.01% |
94,859
-2,777
| -3% | -$346K |
|
3121
iShares Short-Term National Muni Bond ETF
SUB
$10.3B
| $11.8M | ﹤0.01% |
112,667
-1,063
| -0.9% | -$111K |
|
|
AKTS
3122
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $11.8M | ﹤0.01% |
3,821,153
+544,748
| +17% | +$1.68M |
|
3123
Humacyte
HUMA
$243M
| $11.8M | ﹤0.01% |
3,803,240
-207,162
| -5% | -$640K |
|
3124
Mineralys Therapeutics
MLYS
$2.89B
| $11.7M | ﹤0.01% |
+749,689
| New | +$11.7M |
|
3125
Cato Corp
CATO
$91.3M
| $11.7M | ﹤0.01% |
1,320,785
-15,393
| -1% | -$136K |
|